BR9916263A - Derivados de piperazina etilamida com atividade sobre receptor de 5-ht1a - Google Patents
Derivados de piperazina etilamida com atividade sobre receptor de 5-ht1aInfo
- Publication number
- BR9916263A BR9916263A BR9916263-6A BR9916263A BR9916263A BR 9916263 A BR9916263 A BR 9916263A BR 9916263 A BR9916263 A BR 9916263A BR 9916263 A BR9916263 A BR 9916263A
- Authority
- BR
- Brazil
- Prior art keywords
- ethylamide
- activity
- piperazine
- derivatives
- ht1a receptor
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/14—The ring being saturated
Abstract
Patente de Invenção: <B>"DERIVADOS DE PIPERAZINA ETILAMIDA COM ATIVIDADE SOBRE RECEPTOR DE 5-HT1A". Esta invenção refere-se a compostos de fórmula (I) que são úteis para o tratamento de distúrbio do sistema nervoso central, incluindo ansiedade, depressão, pânico, vício de álcool e droga, disfunção sexual, distúrbios do sono, enxaqueca, obesidade, distúrbios cognitivos e doenças neurodegenerativas.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US21333698A | 1998-12-17 | 1998-12-17 | |
PCT/US1999/029953 WO2000035892A1 (en) | 1998-12-17 | 1999-12-16 | Piperazine ethylamide derivatives with 5-ht1a receptor activity |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9916263A true BR9916263A (pt) | 2001-09-04 |
Family
ID=22794714
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9916263-6A BR9916263A (pt) | 1998-12-17 | 1999-12-16 | Derivados de piperazina etilamida com atividade sobre receptor de 5-ht1a |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP1140882A1 (pt) |
JP (1) | JP2002532481A (pt) |
AU (1) | AU3124100A (pt) |
BR (1) | BR9916263A (pt) |
CA (1) | CA2351860A1 (pt) |
WO (1) | WO2000035892A1 (pt) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8106074B2 (en) | 2001-07-13 | 2012-01-31 | Pierre Fabre Medicament | Pyridin-2-yl-methylamine derivatives for treating opiate dependence |
WO2003099266A2 (en) * | 2002-05-23 | 2003-12-04 | Abbott Laboratories | Acetamides and benzamides that are useful in treating sexual dysfunction |
US20090238761A1 (en) * | 2005-01-03 | 2009-09-24 | Universita Degli Studi Di Siena | Novel Aryl Piperazine Derivatives With Medical Utility |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4895840A (en) * | 1987-06-10 | 1990-01-23 | A. H. Robins Company, Incorporated | N-(aryl-,aryloxy-,arylthio-arylsulfinyl-and arylsulfonyl-)alkyl-N,N'-(or n'n')alkylaminoalkyl ureas and cyanoguanidines |
MX9201991A (es) * | 1991-05-02 | 1992-11-01 | Jonh Wyeth & Brother Limited | Derivados de piperazina y procedimiento para su preparacion. |
GB9200293D0 (en) * | 1992-01-08 | 1992-02-26 | Wyeth John & Brother Ltd | Piperazine derivatives |
US5605896A (en) * | 1992-02-25 | 1997-02-25 | Recordati S.A., Chemical And Pharmaceutical Company | Bicyclic heterocyclic derivatives having α1 adrenergic and 5HT1A activities |
AU7177694A (en) * | 1993-06-23 | 1995-01-17 | Cambridge Neuroscience, Inc. | Sigma receptor ligands and the use thereof |
CA2307114A1 (en) * | 1997-10-22 | 1999-04-29 | Clint Duane Walker | Arylpiperazines as serotonin reuptake inhibitors and 5-ht1d.alpha. antagonists |
-
1999
- 1999-12-16 CA CA002351860A patent/CA2351860A1/en not_active Abandoned
- 1999-12-16 WO PCT/US1999/029953 patent/WO2000035892A1/en not_active Application Discontinuation
- 1999-12-16 BR BR9916263-6A patent/BR9916263A/pt not_active IP Right Cessation
- 1999-12-16 AU AU31241/00A patent/AU3124100A/en not_active Abandoned
- 1999-12-16 EP EP99965292A patent/EP1140882A1/en not_active Withdrawn
- 1999-12-16 JP JP2000588153A patent/JP2002532481A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
WO2000035892A1 (en) | 2000-06-22 |
JP2002532481A (ja) | 2002-10-02 |
CA2351860A1 (en) | 2000-06-22 |
EP1140882A1 (en) | 2001-10-10 |
AU3124100A (en) | 2000-07-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0214825A (pt) | Uréias de 2-aminobenzotiazóis como moduladores de adenosina | |
BR9916326A (pt) | Derivados de 2,3,4,4a-tetrahidro-1h-pirazino(1,2-a)quinoxalin-5-(6h) ona sendo agonistas de 5ht2c | |
BR0112756A (pt) | Composto, composição farmacêutica, métodos para o tratamento de doenças mediadas por prostaglandina, de congestão nasal, asma alérgica, e rinite alérgica, e, uso de um composto | |
BR0312729A (pt) | Novos derivados de indol-3-enxofre | |
BR9912807A (pt) | Uso de derivados de arila (ou heteroarila) azolilcarbinol na fabricação de medicamento para tratamento de distúrbios mediados por excesso de substância p | |
MA30340B1 (fr) | Nouveaux composes | |
BR0107893A (pt) | Agonistas e antagonistas de receptor de melanocortina | |
PT1066036E (pt) | Agentes com actividade relacionada com serotonina para o tratamento da apneia do sono | |
BR0314393A (pt) | Piperazinas heterocìclicas substituìdas para o tratamento de esquizofrenia | |
BR9913512A (pt) | Derivados de 4,4-biarilpiperidina com atividade de receptor de opióide | |
BR0314488A (pt) | Composto, composição farmacêutica e métodos de tratamento | |
AR028705A1 (es) | Bis-arilsulfonas | |
BR0112883A (pt) | Composto de derivado de 3,4-diidroisoquinolina e um agente farmacêutico compreendendo o mesmo como ingrediente ativo | |
BR0315846A (pt) | Tratamento farmacológico para apnéia do sono | |
PA8597301A1 (es) | Derivados de imidazol-4-il-etinil-piridina | |
EE200300167A (et) | Amidoalküülpiperidiini ja -piperasiini derivaadid, neid sisaldav farmatseutiline kompositsioon ningühendite kasutamine närvisüsteemi häirete raviks | |
ECSP045156A (es) | Derivados de indolilalquilamina como ligandos 5-hidroxitriptamina-6 | |
DK1578740T3 (da) | 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet | |
BRPI0417520A (pt) | 1h-pirrolo[3,2-b, 3,2-c, e 2,3-c]piridina-2-carboxamidas substituìdas e análogos relatados como inibidores de caseìna cinase i-epsilon | |
BRPI0409436A (pt) | compostos de 4-fenil-piperidina e a sua utilização como moduladores de receptores de opióides | |
BR9916220A (pt) | Derivados de arilpiperidina e aril-1,2,5,6-tetraidropiridina uréia tendo atividade de receptor 5ht1a | |
DK1187832T3 (da) | Aminoheterocycler, som er anvendelige som farmaceutiske midler | |
BR9916263A (pt) | Derivados de piperazina etilamida com atividade sobre receptor de 5-ht1a | |
DE60221813D1 (de) | Thiazolopyrimidinderivate und deren verwendung als antagonisten des cx3cr1 rezeptors | |
BR0112131A (pt) | Composições farmacêuticas e métodos para uso |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B25D | Requested change of name of applicant approved | ||
B08F | Application fees: dismissal - article 86 of industrial property law |
Free format text: REFERENTE A 6O E 7O ANUIDADES. |
|
B08K | Lapse as no evidence of payment of the annual fee has been furnished to inpi (acc. art. 87) |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1913 DE 04/09/2007. |